Expression of c-fms proto-oncogene product by ovarian cancer cell lines with effects of macrophage colony-stimulating factor on proliferation

Oncology. 1996 Mar-Apr;53(2):99-103. doi: 10.1159/000227544.

Abstract

We studied the production of macrophage colony-stimulating factor (M-CSF) and the expression of c-fms mRNA, an M-CSF receptor, in four human ovarian cancer cell lines. All four cell lines expressed c-fms mRNA while three secreted M-CSF into the culture medium. The exogenous administration of M-CSF caused no significant enhancement of cellular proliferation in any cell line. Interestingly, the proliferation of KK cells was not affected by anti-M-CSF antibody. These results, taken together with the fact that ovarian cancer cells simultaneously produce M-CSF and c-fms, suggest that an autocrine mechanism may modulate cellular proliferation.

MeSH terms

  • Adenocarcinoma / metabolism*
  • Adenocarcinoma / pathology
  • Antibodies, Anti-Idiotypic / pharmacology
  • Cell Division / drug effects
  • Female
  • Humans
  • Macrophage Colony-Stimulating Factor / biosynthesis*
  • Macrophage Colony-Stimulating Factor / immunology
  • Macrophage Colony-Stimulating Factor / pharmacology
  • Oncogene Protein gp140(v-fms) / biosynthesis*
  • Ovarian Neoplasms / metabolism*
  • Ovarian Neoplasms / pathology
  • Proto-Oncogene Mas
  • RNA, Messenger / biosynthesis*
  • Tumor Cells, Cultured

Substances

  • Antibodies, Anti-Idiotypic
  • MAS1 protein, human
  • Oncogene Protein gp140(v-fms)
  • Proto-Oncogene Mas
  • RNA, Messenger
  • Macrophage Colony-Stimulating Factor